Showing 11-15 of 121 real-world data insights & analytics:
OM1 Launches Parkinson’s Disease Premium Dataset to Expand Real-World Evidence in Neuroscience

Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1, the leading real-world data and technology company focused on chronic conditions, today announced the launch of its Parkinson’s Disease (PD) premium dataset and the enhancement of its Mental Health & Neuroscience Real-World Data Network. The dataset includes more than 7,000 patients prospectively followed by neurologists in hundreds of clinics across[…]

12 New Ways Companies Are Helping to Improve Adherence

PM360 July 13, 2023 Read the full article>> Reasons for Discontinuation (RfD) Analytics Report An estimated 50% of patients with a prescription for a chronic condition stop taking it within the first year, leading to worse outcomes and nearly $250 billion lost revenue annually for the pharmaceutical industry. To combat this, OM1 launched its Reasons for Discontinuation[…]

Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials

Register to watch>> Join a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data. Extracting as much information as possible from real-world datasets is essential for understanding the complete patient journey. Subtle patterns in[…]

How Real-World Data Can Contribute to Improved Mental Health Treatment

PM360 MAY 25, 2023 Andrew Matthius Read the full article>> Mental health continues to be a national crisis that is only becoming more prevalent, especially since the pandemic. According to the National Alliance on Mental Illness (NAMI), 22.8% of U.S. adults experienced mental illness in 2021, which represents about 1 in 5 adults or 57.8 million[…]

1 2 3 4 5 … 25